← Leaderboards
Elizabeth B Norton
Tulane University Of Louisiana
$7,814,261
Attributed
$7,814,261
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2015–25$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,814,261 · 6
By mechanism
R01$5,530,953 · 2
U54$1,336,593 · 2
R56$946,715 · 2
Top collaborators
No co-investigators on record.
Most similar at Tulane University Of Louisiana
Same institution · by research overlap
- Jacob P. Bitoun$2,066,763
- Nicholas James Maness$2,261,000
- James E Robinson$7,547,091
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponseAntibodiesMemoryImmunityMucosal ImmunityAntigensVaccinationImmune ResponseVaccinesProteinsSafetyVaccine TrialCyclic AmpImmunizationIn VivoVaccine DevelopmentVaccine EfficacyDesignSignal TransductionAdjuvantDoseClinical TrialsImmunogenicityToxin
Grant awards (15)
Evaluation of Memory Responses and Biomarkers from a Phase IEnterotoxigenic Escherichia coli (ETEC) Intramuscular SubunitVaccine with dmLT Adjuvant$679,209
R01 · FY2025 · AI · contact PI
Evaluation of Memory Responses and Biomarkers from a Phase IEnterotoxigenic Escherichia coli (ETEC) Intramuscular SubunitVaccine with dmLT Adjuvant$702,414
R01 · FY2024 · AI · contact PI
Evaluation of Memory Responses and Biomarkers from a Phase IEnterotoxigenic Escherichia coli (ETEC) Intramuscular SubunitVaccine with dmLT Adjuvant$710,520
R01 · FY2023 · AI · contact PI
Evaluation of Memory Responses and Biomarkers from a Phase IEnterotoxigenic Escherichia coli (ETEC) Intramuscular SubunitVaccine with dmLT Adjuvant$705,908
R01 · FY2022 · AI · contact PI
Cellular Immunity and Memory to SARS-CoV-2$396,512
U54 · FY2022 · CA · contact PI
Evaluation of Memory Responses and Biomarkers from a Phase 1 Enterotoxigenic Escherichia coli (ETEC) Intramuscular Subunit Vaccine with dmLT Adjuvant$685,989
R56 · FY2021 · AI · contact PI
Evaluation of Memory Responses and Biomarkers from a Phase IEnterotoxigenic Escherichia coli (ETEC) Intramuscular SubunitVaccine with dmLT Adjuvant$669,587
R01 · FY2021 · AI · contact PI
Cellular Immunity and Memory to SARS-CoV-2$940,081
U54 · FY2020 · CA · contact PI
Mechanisms of dmLT Adjuvant$260,726
R56 · FY2020 · AI · contact PI
Development of Novel Adjuvants LTA and LTA1$376,250
R01 · FY2019 · AI · contact PI
Development of Novel Adjuvants LTA and LTA1$370,189
R01 · FY2019 · AI · contact PI
Development of Novel Adjuvants LTA and LTA1$376,250
R01 · FY2018 · AI · contact PI
Development of Novel Adjuvants LTA and LTA1$376,250
R01 · FY2017 · AI · contact PI
Development of Novel Adjuvants LTA and LTA1$376,250
R01 · FY2016 · AI · contact PI
Development of Novel Adjuvants LTA and LTA1$188,126
R01 · FY2015 · AI · contact PI